EXECUTIVE EMPLOYMENT AGREEMENTEmployment Agreement • August 3rd, 2020 • Checkmate Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 3rd, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into this 8th day of April, 2020 (the “Effective Date”), by and between Checkmate Pharmaceuticals, Inc., a Delaware corporation (“Company”), and Arthur M. Krieg (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTEmployment Agreement • August 3rd, 2020 • Checkmate Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 3rd, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into this 26th day of November, 2018 and effective as of the 5th day of December, 2018 (the “Effective Date”), by and between Checkmate Pharmaceuticals, Inc., a Delaware corporation (“Company”), and Barry Labinger (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTEmployment Agreement • August 3rd, 2020 • Checkmate Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 3rd, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into this 14th day of October 2019 (the “Effective Date”), by and between Checkmate Pharmaceuticals, Inc., a Delaware corporation (“Company”), and Kleem Chaudhary, Ph.D. (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTEmployment Agreement • August 3rd, 2020 • Checkmate Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 3rd, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into this 19th day of September, 2019 (the “Effective Date”), by and between Checkmate Pharmaceuticals, Inc., a Delaware corporation (“Company”), and James E. Wooldridge, M.D. (“Executive”).